Is a single dose of Doxycycline (Doxycycline) effective for prophylaxis against sexually transmitted infections (STIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxycycline Post-Exposure Prophylaxis for STI Prevention

Yes, a single 200 mg dose of doxycycline taken within 72 hours after condomless sex is effective for preventing bacterial STIs, specifically reducing syphilis and chlamydia by over 70% and gonorrhea by approximately 50% in gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW) with recent bacterial STI history. 1, 2

Who Should Receive Doxy-PEP

Providers should offer doxy-PEP through shared decision-making to: 1, 2

  • MSM and TGW with at least one bacterial STI (syphilis, chlamydia, or gonorrhea) diagnosed in the past 12 months 1, 2
  • This represents a Strength AI recommendation (strong recommendation, high-quality evidence) from the 2024 CDC guidelines 1

For populations NOT included in formal recommendations: 1

  • Cisgender women
  • Cisgender heterosexual men
  • Transgender men
  • Other queer and nonbinary persons
  • Evidence is currently insufficient to recommend for or against doxy-PEP in these groups 1

Clinical judgment consideration: Although not directly studied, doxy-PEP could be discussed with MSM and TGW without recent bacterial STI diagnosis who will be participating in high-risk sexual activities 1

Dosing Protocol

The exact regimen is: 1, 2

  • 200 mg doxycycline (any formulation) as a single dose 1, 2
  • Taken as soon as possible within 72 hours after oral, vaginal, or anal sex 1, 2
  • Maximum dose: 200 mg per 24-hour period 1, 2
  • Prescribe enough doses based on anticipated sexual activity until next visit 1, 2

Administration Instructions to Prevent Side Effects

To minimize esophagitis and gastrointestinal upset: 1, 2

  • Take on a full stomach with a full glass of liquid (at least 200 mL of water) 1, 2
  • Remain upright for at least 1 hour after taking 1, 2

Critical drug-food interactions requiring 2-hour separation: 1, 2

  • Dairy products (milk, yogurt, cheese, calcium-fortified juice) 2, 3
  • Antacids containing calcium, magnesium, or aluminum 1, 2
  • Supplements containing calcium, iron, magnesium, or sodium bicarbonate 1, 2
  • The 2-hour separation applies both BEFORE and AFTER taking doxycycline 2, 3

Important contraindication: 4

  • Do not prescribe doxy-PEP to patients taking isotretinoin or other retinoids due to risk of pseudotumor cerebri (increased intracranial pressure that can cause permanent vision loss) 4

No clinically relevant interactions with gender-affirming hormonal therapy 1

Comprehensive Sexual Health Approach Required

At initial doxy-PEP visit: 1, 2

  • Screen for gonorrhea and chlamydia at all anatomic sites of exposure (oral, rectal, urogenital) 1
  • Serologic testing for syphilis 1
  • HIV screening per CDC HIV PrEP guidelines if not on PrEP; consider every 3-6 months if not receiving HIV PrEP 1
  • Counsel on condom use, partner reduction, and HIV PrEP/PEP as indicated 1

Counseling on benefits and harms must include: 1

  • Known side effects: photosensitivity, esophagitis, gastrointestinal intolerance (nausea, vomiting, diarrhea) 1, 2
  • Potential for antimicrobial resistance development in other pathogens and commensal organisms 1
  • Unknown long-term effects on the microbiome 1

At follow-up visits every 3-6 months: 1, 2

  • Screen for gonorrhea, chlamydia, and syphilis 1
  • Assess for doxycycline side effects 1
  • Re-assess continued need for doxy-PEP 1
  • Provide risk reduction counseling and condoms 1
  • Prescribe enough doses until next visit 1

Evidence Supporting Efficacy

Meta-analysis findings demonstrate: 5

  • Doxy-PEP reduces incidence of first STI by approximately 46% (HR 0.538,95% CI 0.337-0.859) 5
  • Chlamydia incidence reduced by approximately 71% (RR 0.291,95% CI 0.093-0.911) 5
  • Combined reduction of syphilis, gonorrhea, and chlamydia by two-thirds in high-risk populations 6

The CDC concludes that doxy-PEP has demonstrated benefit in reducing incident syphilis, chlamydia, and gonorrhea in MSM and TGW at increased risk, representing a new approach to STI prevention in the context of rising national incidence rates 1

Common Pitfalls to Avoid

Medication interactions: 1

  • Review ALL medications including over-the-counter drugs and supplements before prescribing 1
  • Patients often don't realize the 2-hour dairy separation applies both before AND after taking doxycycline 2, 3

Photosensitivity management: 2

  • Advise avoiding prolonged sun exposure 2
  • Use UVA-absorbing sunscreens during treatment 2
  • Consider taking doxycycline in the evening when possible 2

Patient education emphasis: 1

  • Take doxycycline exactly as prescribed and only for its intended purpose 1
  • Do not share medication with others 2
  • Do not exceed 200 mg per 24 hours 1, 2

Ongoing Monitoring and Future Considerations

The CDC notes that ongoing studies are evaluating: 1

  • Long-term antimicrobial resistance patterns 1
  • Population-level impact of doxy-PEP implementation 7, 8
  • Guidelines will be updated as additional data become available 1

Concerns about antimicrobial resistance must be weighed against STI-related morbidity in the context of rising bacterial STI rates, particularly the syphilis epidemic 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Doxycycline Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dairy Interaction with Doxycycline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Doxycycline and Isotretinoin Interaction for STI Post-Exposure Prophylaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Doxycycline Postexposure Prophylaxis for Sexually Transmitted Infection Prevention.

Journal of the American Board of Family Medicine : JABFM, 2025

Research

Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.